Board of Managers

Board Members

Ronald Harrington
Ronald Harrington
Chairman, Entrepreneur and Philanthropist Read more.
Carmen Bozic, MD
Senior Vice President of Global Development, Biogen Read more.
Michael Martin, PhD
Head of Takeda Ventures, Inc. Read more.
Robert Reitman
Robert Reitman
Principal, Riverbend Advisors Read more.
Baiju Shah
Chief Executive Officer, BioMotiv Read more.
Jonathan Stamler, MD
President, Harrington Discovery Institute Read more.
David U’Prichard, PhD
Chairman, Advisory Board Read more.

Board Observers

Cell Features OptiKira’s Technology for Reversing Diabetes
CLEVELAND, April 26, 2017 – OptiKira founders Dr. Feroz Papa (UCSF), Dr. Bradley Backes (UCSF), and Dr. Dustin Maly (University Read more.
Takeda, HDI Partner to Advance Rare Diseases Treatments
Harrington Discovery Institute (HDI) and Takeda Pharmaceuticals have teamed up to support the translation of research into treatments for rare Read more.
Nynex Therapeutics Launched to Target Oncogenic Proteins in the Treatment of Cancer
CLEVELAND, OH – March 16, 2017 Formed in partnership between BioMotiv and University of Michigan, Nynex will develop breakthrough drugs that inhibit Read more.
2017 Harrington Prize for Innovation in Medicine Awarded
CLEVELAND, OH – March 15, 2017 The Harrington Discovery Institute and The American Society for Clinical Investigation are pleased to announce that Read more.
Filling the Drug Discovery Abyss
Drug Discovery World Winter 2017 Read more.
OptiKira Receives Significant Grant from ALS Association
CLEVELAND, OH – February 9, 2017 OptiKira has been awarded a $498,500 grant to support the development of their platform Read more.
Allinaire Therapeutics Receives Significant Funding
CLEVELAND, OH – January 26, 2017   Allinaire Therapeutics, a respiratory therapeutics start-up launched by BioMotiv, has recently received new Read more.
SapVax Launched to Develop Novel Cancer Vaccines Platform
CLEVELAND, OH – January 17, 2017 SapVax will develop a suite of first-in-class cancer vaccines based on a novel self-adjuvanting peptide platform technology Read more.
Harrington Discovery Institute Announces 15 New Scholars
CLEVELAND, OH – January 16, 2017 The Harrington Discovery Institute (HDI) at University Hospitals in Cleveland, Ohio has announced 15 new Read more.
BioMotiv and Biogen Expand Partnership to Include Ophthalmology
September 6, 2016 Read more.
Licensing Executives Society Annual Meeting
October 23-26, 2016 Read more.
Partnering for Cures
November 13-15, 2016 Read more.
Arix Bioscience Supports OptiKira, a Company Developing Drugs to Fight Blindness
June 13, 2016 Read more.
Allinaire Therapeutics Launches to Combat Pulmonary Diseases
May 2, 2016 Read more.
BioTrinity 2016
April 25-27, 2016 Read more.
Arix Bioscience and BioMotiv Announce Strategic Partnership
April 18, 2016 Read more.
BioMotiv partners with London-based Arix Bioscience
Crain's Cleveland Business - April 18, 2016 Read more.
BioMotiv and Charles River Laboratories Enter Into Strategic Partnership
April 14, 2016 Read more.
BioMotiv secures up to $10 million investment from Charles River Laboratories
Crain's Cleveland Business - April 14, 2016 Read more.
MedCity Invest
April 12-13, 2016 Read more.
Sujana Biotech Receives NIH Grant
March 29, 2016 Read more.
Grant will help BioMotiv spinoff develop drugs to fight inflammation
Crain's Cleveland Business - March 29, 2016 Read more.
Harrington Discovery Institute and ASCI honor Jeffrey M. Friedman, MD, PhD
March 15, 2016 Read more.
Dr. Dan R. Littman, Founder of Orca Pharmaceuticals, Honored with Vilcek Prize in Biomedical Science
March 8, 2016 Read more.
Z53 Therapeutics, a New Oncology Startup-Up, Launches to Combat Cancer-Associated Mutation
March 4, 2016 Read more.
Dr. Daniel I. Simon, Founder of Sujana Biotech, Receives American College of Cardiology Top Honor
March 4, 2016 Read more.
BioMotiv, Rutgers University launch startup to fight cancer
Crain's Cleveland Business - February 29, 2016 Read more.
Harrington Discovery Institute Announces 2016 Harrington Scholar-Innovator Awards
January 13, 2016 Read more.
Bristol-Myers Squibb could pay handsomely for local company’s cancer drugs
Crain's Cleveland Business - January 8, 2016 Read more.
Financing High-Risk Medical Research
FasterCures - January 2016 Read more.
Ron Harrington Receives Prestigious Horatio Alger Award
December 2, 2015 Read more.
Orca Pharmaceuticals Partners RORgamma Inhibitors to Brickell Biotech
November 24, 2015 Read more.
Brickell Biotech Secures Exclusive Worldwide Rights to a Novel Class of ROR-gamma Inhibitors for Psoriasis and Other Autoimmune Diseases
Businesswire - November 24, 2015 Read more.
Partnering for Cures
November 1-3, 2015 Read more.
Cavendish Global Health Impact Forum
October 25-27, 2015 Read more.
Indiana Life Sciences Summit
October 14, 2015 Read more.
OptiKira Awarded Two NIH Grants
September 30, 2015 Read more.
Biotech startup OptiKira receives federal grants for work on cell death prevention
Crain's Cleveland Business - September 30, 2015 Read more.
BioMotiv and Biogen Form Strategic Partnership
September 21, 2015 Read more.
Biogen plans to invest $15 million in BioMotiv LLC over five years
Crain's Cleveland Business - September 21, 2015 Read more.
BioPharm America 2015
September 15-17, 2015 Read more.
Cutting Edge Drug Discovery & Development in Michigan
September 10, 2015 Read more.
Harrington Discovery Institute Announces 2015 Partnership Scholars
August 26, 2015 Read more.
Sujana Biotech, a New Biotech Start-up, Launched by BioMotiv
July 1, 2015 Read more.
University Hospitals appoints Mukesh K. Jain, MD as new Chief Scientific Officer
March 13, 2015 Read more.
harrington Discovery Institute Opens 4th Annual Grant Competition & Increases Funding Levels
March 3, 2015 Read more.
Orca Pharmaceuticals and AstraZeneca Announce Development Partnership
February 25, 2015 Read more.
AstraZeneca bets $122.5M on oral autoimmune drugs
FierceBiotech - February 25, 2015 Read more.
OptiKira, a New Biotech Start-up, Created to Develop Drugs to Prevent Cell Death Caused by the Unfolded Protein Response
Click here to read the full press release. Read more.
Harrington Discovery Institute Announces 2015 Harrington Scholar-Innovator Awards
December 09, 2014 Read more.
Harrington Discovery Institute Partners with University of Oxford to Expand Project to the UK
November 12, 2014 Read more.
Rust No More: Ohio’s investments into research are ushering the state from a manufacturing past into a knowledge-economy future
Nature - October 30, 2014 Read more.
BioOhio
October 16, 2014 Read more.
Foundation Fighting Blindness and Harrington Discovery Institute Launch National Initiative
October 8, 2014 Read more.
Takeda Pours $25M Into Biotech Dealmaker BioMotiv
FierceBiotech - September 26, 2014 Read more.
BioMotiv and Takeda Pharmaceutical Company Enter Into Strategic Partnership
September 25, 2014 Read more.
RESI Conference
September 17, 2014 Read more.
BIO International Conference
June 23-26, 2014 Read more.
BioCentury Emerging Company Profile: Dual Therapeutics
BioCentury - June 23, 2014 Read more.
Harrington Discovery Institute Awarded $25 Million Grant
June 12, 2014 Read more.
Alzheimer’s Drug Discovery Foundation & Harrington Discovery Institute Announce Award Recipients
June 6, 2014 Read more.
Researchers from Ohio State, Emory receive grants from Harrington Discovery Institute and Alzheimer’s Drug Discovery Foundation
The Plain Dealer - June 6, 2014 Read more.
Two universities awarded support and funding from Harrington Discovery Institute, Alzheimer’s Drug Discovery Foundation
Crain's Cleveland Business - June 6, 2014 Read more.
New York Bio
May 14-15, 2014 Read more.
Oncology Start-up Dual Therapeutics Receives Investment from the Partnership Fund for New York City
May 2, 2014 Read more.
Orca Pharmaceuticals Achieves Development Milestone and Secures Additional Funding
April 28, 2014 Read more.
BioMotiv Aims to Launch Drugs – and a Local Industry, with Baiju Shah
Crain's Cleveland Business - April 22, 2014 Read more.
TEDxCLE
April 4, 2014 Read more.
RESI Conference
March 24, 2014 Read more.
harrington Discovery Institute at University Hospitals Case Medical Center Begins 3rd Annual Grant Competition to Support Drug Discovery
March 18, 2014 Read more.
Betting on Biotech Remains a Gamble Worth Taking
The Plain Dealer - March 18, 2014 Read more.
Northeast Ohio Positioned Well to Thrive in Medical Fields, But There Are Challenges, Cleveland Connects Panel Says
The Plain Dealer - March 11, 2014 Read more.
Cleveland Connects: Building on Biotech
March 10, 2014 Read more.
Innovator Capital Rationing
BioCentury - March 10, 2014 Read more.
BioMotiv to Develop BioAtla’s TH22 Pathway-Directed Antibody for IBD, Oncologic Indications
Pharmaceutical Business Review - February 20, 2014 Read more.
BioMotiv Launches Kodosil Bio Targeting IL-22
February 19, 2014 Read more.
BioMotiv Launches Company to Deal with Inflammatory Bowel Disease
Crain's Cleveland Business - February 19, 2014 Read more.
Inaugural Harrington Prize for Innovation in Medicine Awarded
February 11, 2014 Read more.
Harrington Discovery Institute Announces 2014 Harrington Scholar-Innovator Awards
December 10, 2013 Read more.
Harrington Institute Leader Receives American Heart Association’s Distinguished Scientist Award
November 21, 2013 Read more.
Harrington Institute Leader Receives American Heart Association’s Distinguished Scientist Award
University Hospitals - November 21, 2013 Read more.
Life Sciences Future
November 13, 2013 Read more.
BioMotiv and the Foundation Fighting Blindness Fund Project to Identify Vision-Saving Molecules
November 1, 2013 Read more.
The Alzheimer’s Drug Discovery Foundation partners with Harrington Discovery Institute at University
October 24, 2013 Read more.
Harrington Discovery Institute, Alzheimer’s Drug Discovery Foundation Team Up
Crain's Cleveland Business - October 24, 2013 Read more.
Dual Therapeutics, a New Oncology Start-up, Is Launched by BioMotiv and the Icahn School of Medicine
October 09, 2013 Read more.
Dual Therapeutics Forms to Develop New Cancer Therapeutics Discovered at Mount Sinai
MedCity News - October 9, 2013 Read more.
Cures Within Reach and BioMotiv Announce a Rediscovery Research Partnership
9/16/2013 Read more.
BioMotiv LLC Forms Partnership with Nonprofit to Find New Uses for Existing Medicines
Crain's Cleveland Business - September 16, 2013 Read more.
Cleveland Biotech Accelerator BioMotiv Launches Its First Company in England
The Plain Dealer - September 11, 2013 Read more.
BioMotiv and New York University join forces to form Orca Pharmaceuticals
September 9, 2013 Read more.
Biotech Accelerator BioMotiv, NYU Unveil a New Spinoff for Inflammatory Disease Treatment
MedCity News - September 9, 2013 Read more.
BioMotiv LLC Spins Off First Startup
Crain's Cleveland Business - September 9, 2013 Read more.
BioMotiv LLC Gains San Diego Firm as Investment Partner
Crain's Cleveland Business - August 13, 2013 Read more.
Cleveland Drug-Discovery Company BioMotiv Attracts New Millions and a Key Partner
The Plain Dealer - August 12, 2013 Read more.
BioMotiv and Torrey Pines Investment Announce Multi-Million Dollar Partnership
August 12, 2013 Read more.
Biotech Accelerator BioMotiv Gets a $20M Commitment from New Investor
Fierce Biotech - August 12, 2013 Read more.
Cleveland Drug-Discovery Company BioMotiv Attracts New Millions and a Key Partner
The Plain Dealer - August 12, 2013 Read more.
BioMotiv, Torrey Pines to Co-invest Up to $40M
BioCentury - August 12, 2013 Read more.
Collaboration With Torrey Pines Adds To BioMotiv’s Early Momentum
The Pink Sheet - August 12, 2013 Read more.
Financings of the Fortnight Gets Comfortable In Genes
In Vivo Blog - August 8, 2013 Read more.
BioMotiv Secures $46 Million in Funding
August 5, 2013 Read more.
BioMotiv Raises $25M in New Capital
Crain's Cleveland Business - August 5, 2013 Read more.
BioMotiv Garners $46M for Early-Stage Licensing Deals, R&D Work
Fierce Biotech - August 5, 2013 Read more.
With $46M in Tow, Accelerator/Investor BioMotiv Puts to Work a New Model for Drug Development
MedCity News - August 5, 2013 Read more.
BioMotiv Raises $25 Million
BioCentury - August 5, 2013 Read more.
BioMotiv: An Rx For Asset Financing Without the Venture Headache
Start-Up - June 14, 2013 Read more.
BioMotiv: An Rx For Asset Financing Without the Venture Headache
Start-Up - June 14, 2013 Read more.
What’s in Store for Biopharma?
Business Xpansion Journal - April 21, 2013 Read more.
Ohio Venture Association
April 13, 2013 Read more.
First Harrington Distinguished Scholar Brings Breast Cancer Research to Cleveland
The Plain Dealer - January 24, 2013 Read more.
The Harrington Project Named One of the Top 10 Stories of 2012 by Association of University Technology Managers
AUTM Newsbrief - December 27, 2012 Read more.
Profit/Non-Profit Partners to Carry Biotech Innovations Across Valley of Death
Tech Transfer eNews - December 12, 2012 Read more.
Mid-America Health Care Venture Forum
December 4, 2012 Read more.
Harrington Discovery Institute at University Hospitals Case Medical Center Chooses First 10 Harrington Scholars
The Plain Dealer - December 4, 2012 Read more.
There’s a New Twist to Early Stage Drug Discovery Financing: Technology Without the Team (Video)
MedCity News - December 4, 2012 Read more.
US Japan Health Sciences Dialogue
November 29, 2012 Read more.
Partnering for Cures
November 29, 2012 Read more.
Speeding Up the Discovery of Drugs
Bloomberg Businessweek - November 29, 2012 Read more.
Speeding Up the Discovery of Drugs
Bloomberg Businessweek - November 29, 2012 Read more.
The Few and The Proud: The Biotech Startup Class of 2012
Xconomy - November 26, 2012 Read more.
BioMotiv Aims to Help Drugs Cross Valley of Death
Crain's Cleveland Business - November 19, 2012 Read more.
Corporate Club
Cleveland, November 14, 2012 Read more.
The Biotech ‘Valley of Death’ Has Become the Uncrossable Canyon: An Innovative Approach to Funding
MedCityNews - September 21, 2012 Read more.
BioMotiv, Drug-Development Company Tied to University Hospitals, Gets $21 Million Investment
Cleveland Plain Dealer - September 6, 2012 Read more.
BioMotiv Secures $21 Million in Initial Funding
September 5, 2012 Read more.
BioMotiv Secures $21 Million From Its Founding Investors
Crain's Cleveland Business - September 5, 2012 Read more.
BioMotiv Launches Development Operation, Names Leadership Team
August 20, 2012 Read more.
BioMotiv Names New CEO
August 20, 2012 Read more.
BioMotiv to Be Middleman For Crossing Valley of Death
BioWorld Today - July 20, 2012 Read more.
Bridging the Valley of Death
The Burrill Report - April 2012 Read more.
University Hospitals Launches $250 Million National Initiative to Accelerate New Drug Development Inspired by Physician-Scientists
February 29, 2012 Read more.
University Hospitals Announces National Program Designed to Speed the Discovery of New Drugs
Cleveland Plain Dealer - February 29, 2012 Read more.
Harrington Discovery Institute at University Hospitals Case Medical Center Chooses First 10 Harrington Scholars
The Plain Dealer - December 4, 0201 Read more.
There’s a New Twist to Early Stage Drug Discovery Financing: Technology Without the Team (Video)
MedCity News - December 4, 0201 Read more.